Class A Common Stock Third Quarter 2025 Earnings Conference Call and Webcast. Joining us for today's call are Snail, Inc. Class A Common Stock Chief Financial Officer, Heidy Kingwan Chow, and Senior ...
Papcemias FDA Approval -- Granted full FDA approval in August with the first and only available treatment for all adults with recurrent respiratory papillomatosis (RRP); label is broad with no ...
This is an audio transcript of the Rachman Review podcast episode: ‘The battle for AI supremacy’ Gideon Rachman Hello and ...
Don’t apply solely to work with one person. Faculty members change institutions, often unexpectedly. Sometimes they change ...
Pre-enrollment is currently being held for those students who are new to the School District of Lee County for the 2026-27 ...
Trailing Twelve-Month Core Product Sales -- $37 million, a company record, up from $33.8 million, with distributor and ...
Detailed price information for Bionano Genomics Inc (BNGO-Q) from The Globe and Mail including charting and trades.
KORE (NYSE:KORE) suspended financial guidance for the remainder of fiscal year 2025 due to uncertainty from the announced ...
High school seniors filling out college applications for early action or early decision have been busy this week, as the main ...
The progress we have made in just the past few months validates our decision to focus on our highest value near-term revenue opportunities. As we've discussed previously, we are primarily focused on ...
Hello, everyone, and thank you for joining us for Zeta Global Holdings Corp.'s third quarter 2025 Conference Call. Today's ...
Q3 2025 Earnings Call November 13, 2025 4:30 PM ESTCompany ParticipantsPhillip Chan - CEO & DirectorPeter Mariani ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results